1. Home
  2. FRT vs CYTK Comparison

FRT vs CYTK Comparison

Compare FRT & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Realty Investment Trust

FRT

Federal Realty Investment Trust

HOLD

Current Price

$106.79

Market Cap

9.5B

Sector

Real Estate

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.42

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRT
CYTK
Founded
1962
1997
Country
United States
United States
Employees
320
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
7.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FRT
CYTK
Price
$106.79
$63.42
Analyst Decision
Buy
Strong Buy
Analyst Count
14
18
Target Price
$110.71
$87.56
AVG Volume (30 Days)
795.9K
1.7M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
4.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$5.71
$9.79
Revenue Next Year
$4.65
$302.66
P/E Ratio
$22.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$80.65
$29.31
52 Week High
$110.89
$70.98

Technical Indicators

Market Signals
Indicator
FRT
CYTK
Relative Strength Index (RSI) 51.18 50.87
Support Level $98.70 $59.25
Resistance Level $108.54 $65.93
Average True Range (ATR) 1.93 2.54
MACD -0.37 -0.34
Stochastic Oscillator 40.01 42.07

Price Performance

Historical Comparison
FRT
CYTK

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 27.4 million square feet of retail space and 3,000 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: